Dynavax (DVAX) Presents Data from SD-101 + Keytruda Phase 1/2 in Metastatic Melanoma; One CR Noted
Go back to Dynavax (DVAX) Presents Data from SD-101 + Keytruda Phase 1/2 in Metastatic Melanoma; One CR Noted| Dynavax Technologies Corporation (NASDAQ: DVAX) | Delayed: 11.42 -0.34 (2.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.76 | 52 Week High | $29.86 | |||
| Open | $11.70 | 52 Week Low | $3.20 | |||
| Day High | $11.75 | P/E | N/A | |||
| Day Low | $11.35 | EPS | $-0.41 | |||
| Volume | 1,455,028 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 127.00 +0.12 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.88 | 52 Week High | $65.46 | |||
| Open | $126.82 | 52 Week Low | $47.97 | |||
| Day High | $127.59 | P/E | 86.39 | |||
| Day Low | $125.35 | EPS | $1.47 | |||
| Volume | 7,127,871 | |||||
